SCHEMBL7992290

SCHEMBL7992290

CN(Cc1nc2ncn(Cc3ccc(C(C)(C)C)cc3)c2c(=O)[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
LMNA P02545 1/20 0.42
ABCC8 Q09428 1/20 0.41
KCNJ11 Q14654 1/20 0.41
CACNA1G O43497 1/20 0.40
CACNA1B Q00975 1/20 0.40
CACNA1C Q13936 1/20 0.40
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KMT2A Q03164 2/20 0.37
SCN9A Q15858 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35
NR1H4 Q96RI1 3/20 0.34
CCNE2 O96020 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
BRD4 O60885 1/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987946 0.92 HPGD (0.42) HPGDLMNACACNA1GCACNA1BCACNA1C
SCHEMBL7974303 0.91 HPGD (0.42) HPGDLMNACACNA1GCACNA1BCACNA1C
SCHEMBL7985463 0.91 HPGD (0.52) HPGDCACNA1GCACNA1BCACNA1CALDH1A1
SCHEMBL7988125 0.86 HPGD (0.43) HPGDCACNA1GCACNA1BCACNA1CALDH1A1
SCHEMBL7992288 0.85 ABCC8 (0.41) HPGDLMNAABCC8KCNJ11CACNA1G
SCHEMBL7988933 0.84 GAA (0.44) HPGDCACNA1GCACNA1BCACNA1CALDH1A1
SCHEMBL7975231 0.83 CACNA1G (0.40) HPGDLMNACACNA1GCACNA1BCACNA1C
SCHEMBL7992285 0.82 ABCC8 (0.41) HPGDLMNAABCC8KCNJ11CACNA1G
SCHEMBL7991611 0.82 HPGD (0.42) HPGDLMNACACNA1GCACNA1BCACNA1C
SCHEMBL7988916 0.82 HPGD (0.50) HPGDALDH1A1SMN1; SMN2KMT2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed